Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuangqing Mixture versus oseltamivir for influenza
ChiCTR2400087831Phase 4Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Shuangqing mixture and oseltamivir in influenza (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Time to remission of clinical symptoms and Time to complete defervescence. Started Aug 2024; status: completed.
02
Drugs
Shuangqing mixtureoseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR2400087831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087831.